Well Diagnostics

Well Diagnostics is a biotechnology company based in the Netherlands that specializes in the development and distribution of diagnostic tools for Therapeutic Drug Monitoring (TDM). The company focuses on ELISA kits designed to measure the concentration of biological drugs and the presence of anti-drug antibodies in patient serum. Their products primarily support clinicians in optimizing treatments for chronic inflammatory diseases, such as rheumatoid arthritis and inflammatory bowel disease, by ensuring patients maintain therapeutic drug levels. Well Diagnostics operates out of the Pivot Park life sciences community and collaborates with clinical laboratories and pharmaceutical partners globally. The company's portfolio includes assays for major biologics such as adalimumab, infliximab, and etanercept.